期刊文献+

氧化樟脑合成工艺的改进 被引量:3

Improvement for synthesis of oxocamphor technology
下载PDF
导出
摘要 以樟脑为原料,通过溴化、酯化、还原、水解和氧化反应,最终合成了标题化合物。其结构经1HNMR和13CNMR确证,总收率由6%提高至12%,产物质量分数>96%。改进后的工艺操作简便、安全、条件温和、产物容易提纯。 Oxocamphor was synthesized from camphor as starting materials via the bromination,followed by esterification,reduction,hydrolysis and oxidation.The structure of the target compound was confirmed by 1HNMR and 13CNMR,and the overall yield was increased from 6% to 12%.The purity of the tide compound was over 96% and this procedure was simple,mild and safe,suitable for scale-up production.
出处 《化学试剂》 CAS CSCD 北大核心 2011年第4期350-352,共3页 Chemical Reagents
基金 国家科技部科技人员服务企业行动项目(2009GJB10050) 吉林省科技厅重点项目(20090430)
关键词 氧化樟脑 合成工艺 改进 oxocamphor synthetic process improvement
  • 相关文献

参考文献7

二级参考文献15

  • 1张文杰,钟国赣,江岩,王小明,王中峰.人参二醇组与三醇组皂甙对大鼠心室肌细胞钙通道阻滞作用的单通道分析[J].中国药理学报,1994,15(2):173-176. 被引量:24
  • 2李美珠,钟伟新,李爱华,梁惠玲,雷坚,朱莉芬.舒心丸对实验性心力衰竭的治疗作用[J].中成药,1995,17(9):28-29. 被引量:6
  • 3郭自强,朱陵群,张立平,肖和印.党参对大鼠离体工作心脏缺血/再灌注损伤的保护作用[J].北京中医药大学学报,1995,18(5):39-41. 被引量:76
  • 4阴健.中药现代研究与临床应用(Ⅰ)[M].北京:学苑出版社,1994.381.
  • 5李云霞.心肌力学和心肌收缩性能的评定[J].生理科学进展,1980,11(3):212-212.
  • 6徐胜民 廖家桢.人参强心作用的临床与实验研究[J].北京中医学院,1986,9(3):28-28.
  • 7李云霞.关于左室等容收缩相心收缩指标的实验研究.生理学报,1980,32(2):97-97.
  • 8Bhattacharya Aprba, Mott Graham, Durrwachter John R. Precipitation-induced asymmetric transformation of chiral alpha-amino acids and salts thereof[P].EP : 0499376,1992-08-12.
  • 9Yamada S, Hongo C, Yoshioka R, et al. Preparation of D-p-hydroxyphenylglycine--optical resolution of DL-p-hylroxyphenylglycine with D-3-bromocamphor8-sulfonic acid[J]. Agric Biol Chem, 1979, 43 (2):395-396.
  • 10Bartlett P D,Knox L H.D,L-Ketopinic acid[A].In:Organic Synthesis,Collective Volume 5[M].New York:John Wiley & Sons,1973.689-691.

共引文献8

同被引文献19

  • 1Homma H,Ono H. Effect of trans-pi-oxocamphor on cough and respiratory rales and its action mechanism[J].Nippon Shonika Gakkai Zasshi(Journal of Japan Pediatric Society),1969,(03):364-373.
  • 2Yasuhiko A. Process for preparing d-trans-π-oxocamphor from iso-ketopinic acid[P].Japan,GB:441807 (A),1936.
  • 3Morizo I,Gyokujo K,Yasuhiko A. Method of manufacturing oxocamphor[P].US:1933642 (A),1933.
  • 4关大伟;杜培革;孙彧峰.一种氧化樟脑合成工艺[P],CN:200810050707,2009.
  • 5Walter L M,Angelo P L,Richard N Mccarty. Rearrangement of α-bromocamphoric anhydride[J].American Chemical Society,1966.1754-1762.
  • 6Valerie V,Mohamad R A,U ma N S. Synthesis and absolute configuration of the antiparasitic furanosesquiterpenes (-)-furodysin and (-)-furodysinin.Camphor as a six-membered ring chiral pool template[J].Journal of Organic Chemistry,1991,(01):378-387.
  • 7Hutchinson J H,Money T,Piper S E. Ring cleavage of camphor derivatives:formation of chiral synthons for natural product synthesis[J].Journal of Organic Chemistry,1986.854-861.
  • 8迟莹;刘兴汉.强尔心注射液稳定性的探讨[J]医药工业,1983(01):13-14.
  • 9孟庆勇,吾满江.艾力,张丽静,蔡国星.负载型PCC和PDC氧化剂的制备及对1,4-丁二醇的氧化[J].应用化工,2008,37(3):314-316. 被引量:3
  • 10张朝德,孔古娅,卿德华.强尔心口服液对家兔心力衰竭时舒缩性能的影响[J].成都中医药大学学报,1999,22(1):44-46. 被引量:6

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部